Role of inducible nitric oxide synthase in pharmacological 'preconditioning' with monophosphoryl lipid A

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 6, 1997, Pages 1567-1576

  Zhao, Lin ^a   Weber, Patricia A ^a   Smith, Jerry R ^a   Comerford, Malissa L ^a   Elliott, Gary T ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Cardioprotection; Inducible nitric oxide synthase (iNOS); Ischemia; Monophosphoryl lipid A; Myocardial infarction; Nitric oxide; Preconditioning; Reperfusion

Indexed keywords

AMINOGUANIDINE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHORYL LIPID A; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONDITIONING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME INDUCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031172157     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0390     Document Type: Article

References (51)

1. 1-adrenergic mechanism. Circ Res 73: 656-670.
2. BAXTER GF, MARBER MS, PATEL VC, YELLON DM, 1994. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic predoncitioning. Circulation 90: 2993-3000.
3. CAMERON JS, KIBLER KKA, BERRY H, BARRON DN, SODDER VH, 1996. Nitric oxide activates ATP-sensitive potassium channels in hypertrophied ventricular myocytes. FASEB J 10: A65.
4. COHEN MV, DOWNEY JM, 1996. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med 47: 21-9.
5. DE CATERINA R, LIBBY P, PENG, HB, THANNICKAL VJ, RAJAVASHISTH TB, GIMBRONE MA, SHIN WS, LIAO JK, 1995. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68.
6. DOWNEY JM, COHEN MV, 1995. Signal transduction in ischemic preconditioning. Z Kardiol 84(Suppl. 4): 77-86.
7. DUSTING GJ, MACDONALD PS, 1995. Endogenous nitric oxide in cardiovascular disease and transplantation. Ann Med 27: 395-406.
8. ELLIOTT GT, ZHAO L, MCLEOD RA, FLOYD KW, GRAVES GM, 1995. Cardiac functional preservation by monophosphoryl lipid A in a rabbit model of prolonged regional cardiac ischemia and reperfusion. Int J Immunother 6: 39-48.
9. ELLIOT GT, COMERFORD ML, SMITH JR, ZHAO L, 1996. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, Glibenclamide. Cardiovasc Res (in press).
10. ENGELMAN DT, WATANABE M, MAULIK N, CORDIS GA, ENGELMAN RM, Rousou JA, FLACK JE, DEATON DW, DAS DK, 1995. Larginine reduces endothelial inflammation and myocardial stunning during ischemia and reperfusion. Ann Thorac Surg 60: 1275-1281.
11. FUKUDA H, SAWA Y, KADOBA K, TANIGUCHI K, SHIMAZAKI Y, MATSUDA H, 1995. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 92(Suppl. II): 11-413-11-416.
12. GATO M, LUI Y, YANG X-M, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-21.
13. GROSS G, PIEPER G, FARBER NL, WARLTIER D, HARDMAN H, 1989. Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 63: 11J.
14. GROSS GJ, 1995. Do ATP-sensitive potassium channels play a role in myocardial stunning? Basic Res Cardiol 90: 266-268.
15. GROSS GJ, MEI DA, SCHULTZ JJ, MIZUMURA T, 1996. Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirement? Basic Res Cardiol 91: 31-4.
16. HARTMAN JC, HOUSHYAR H, LEVA, SC, WALL TM, 1995. A role of nitric oxide in myocardial ischemic preconditioning. Circulation (Suppl. 92):I-716.
17. + current in human and rabbit ventricular myocytes. Circ Res 78: 492-98.
18. KAWAMURA T, WAKUSAWA R, OKADA K, INADA S, 1992. Elevation of cytokines during open heart surgery with cardiopulmonary bypass; participation of interleukin 8 and 6 in reperfusion injury. Can J Anesth 40: 1016-1021.
19. KITAKAZE M, HORI M, TAKASHIMA S, SATO H, INOUE M, KAMADA T, 1993. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Circulation 87: 208-215.
20. LUSS H, WALKINS SC, FREESWICK PD, IMRO AK, NUSSLER AK, BILLIAR PR, SIMMONS RL, DEL NIDO PJ, MCGOWAN FX JR, 1996. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 27: 2015-2029.
21. MARBER MS, LATCHMAN DS, WALKER JM, YELLON DM, 1993. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272.
22. MAULIK N, ENGELMAN DT, WATANABE M, ENGLEMAN RM, MAULIK G, CORDIS GA, DAS DK, 1995. Nitric oxide signaling in ischemic heart. Cardiovasc Res 30: 593-601.
23. MAULIK N, ENGELMAN DT, WATANABE M, ENGLEMAN RM, DAS DK, 1996. Nitric oxide - a retrograde messenger for carbon monoxide signaling in ischemic heart. J Mol Cell Biochem (In press).
24. MCKENNA TM, LI S, TAO S, 1995. PKC mediates LPS and phorbol-induced cardiac cell nitric oxide synthase activity and hypo contractility. Am J Physiol 269: (Heart Circ Physiol 38): H1891-1898.
25. + channels mediate the cardioprotective effect of monophosphoryl lipid A. Circulation (Suppl. 92): I388.
26. MIZUMURA T, NITHIPATIKOM K, GROSS GJ, 1995. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release and neutrophil function in dogs. Circulation 92: 1236-1245.
27. MULLANE KM, KRAEMER R, SMITH B, 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14: 157-167.
28. MURRY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
29. MURRY CE, RICHARD VJ, REIMER KA, JENNINGS RB, 1990. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931.
30. MURRY CE, RICHARD VJ, JENNINGS RB, REIMER KA, 1991. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260: H796-804.
31. PABLA R, BUDA A, FLYNN DM, BLESSÉ SA, SHIN AM, CURTIS MJ, LEFER DJ, 1996. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78: 65-72.
32. PAN J, BURGHER KL, SZCZEPANIK AM, RINGHEIM GE, 1996. Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J 314: 889-894.
33. PARRATT JR, SZEKERES L, 1995. Delayed protection of the heart against ischemia. TIPS 16: 351-355.
34. PRZYKLENK K, ZHAO L, KLONER RA, ELLIOTT GT, 1996. Cardioprotection with preconditioning and MLA: Role of adenosine regulating enzymes? Am J Physiol 271 (Heart Circ Physiol 40): H1004-1014.
35. ROWLAND RT, CLEVELAND JC, MENG X, Ho L, HARKEN AH, BROWN JM, 1996. A single endotoxin challenge induces delayed myocardial protection against infarction. J Surg Res 63: 193-198.
36. SHINDO T, IKEDA U, OHKAWA F, KAWAHARA Y, YOKOYAMA M, SHIMADA K, 1995. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 29: 813-819.
37. SQUADRITO F, ALTAVILLA D, ZINGARELLI B, IOCULANO M, CALAPAI G, CAMPO G, MICELI A, CAPUTI A, 1993. Tumor necrosis factor involvment in myocardial ischemia-reperfusion injury. European J of Pharmacol 237: 223-230.
38. SUZUKI H, WOLF W-P, AKIYAMA K, HORSTMAN D, GRANT P, CANNAVINO C, BING RJ, 1996. Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle. Proc Assoc Amer Physicians 108: 173-178.
39. TASHIRO H, SHIMOKAWA H, YAMAMOTO K, NAGANO M, MOMOHARA M, MURAMATU K, TAKESHITA A, 1995. Monocyte-related cytokines in acute myocardial infarction. Am Heart J 130: 446-452.
40. VAN WINKLE DM, THORNTON JD, DOWNEY DM, DOWNEY JM, 1991. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Cor Art Dis 2: 613-619.
41. VEGH A, PAPP JG, PARRATT JR, 1994. Prevention by dexamethasone of the marked antiarrythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081-1082.
42. VEGH A, PAPP JG, PARRATT JR, 1996. Pretreatment with monophosphoryl lipid A (MPL-C) reduces ischemia-reperfusion-induced arrhythmias in dogs. J Mol Cell Cardiol 28: A56.
43. ATP channels in the mechanism of cardioprotective ischemic preconditioning. Circulation (Suppl. 92): I-252.
44. WEYRICH AS, MA X-L, LEFLER AM, 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288.
45. YAMAGUCHI-TAKAIHARA K, IHARA Y, OGATA A, YOSHIZAKI K, AZUMA J, KISHIMOTO T, 1995. Hypoxic stress induces cardiac myocytes-derived interleukin-6. Circulation 91: 1520-1524.
46. YAO Z, AUCHAMPACH JA, PIEPER GM, GROSS G, 1993. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovascular Res 27: 832-838.
47. YAO Z, ELLIOTT GT, GROSS GJ, 1995. Monophosphoryl lipid A (MLA) preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs. Pharmacol 51: 152-159.
48. YELLON DM, BAXTER GF, 1995. A 'second window of protection' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell cardiol 27: 1023-1034.
49. YOSHIDA K-I, MAAIEH MM, SHIPLEY JB, DOLORESCO M, BERNARDO NL, QIAN YZ, ELLIOT GT, KUKREJA RC, 1996. Monophosphoryl lipid A induces pharmacologie 'preconditioning' in rabbit hearts without concomitant expression of 70-kilodalton heat shock protein. Mol Cell Biochem 156: 1-8.
50. ZHAO ZQ, McGEE S, NAKINISHI K, TOOMBS CF, JOHNSON WE, ASHAR MS, VINTEN-JOHANSEN J, 1993. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88: 709-719.
51. ZHAO L, KIRSCH CC, HAGEN SR, ELLIOTT GT, 1996. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). J Mol Cell Cardiol 28: 197-208.